Invectys
Entity

  • Invectys

    Created in 2010
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    2,620

  • Activities

    deeptech biotech

  • Entity types

    Startup

  • Location

    12 Rue Jean Antoine de Baïf, 75013 Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 22

  • Engaged corporates

    1
    1 0

  • Added in Motherbase

    1 year, 7 months ago
Description
  • Value proposition

    Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers

    Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product.
    Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens.

    oncology, immunotherapy, and biotech

  • Original language

    Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers

    Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product.
    Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens.

Corporate interactions BETA
Corporate TypeTweets Articles
France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Other

19 Oct 2023


Similar entities
Last news
Show all articles
Social network dynamics